| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/24/1999 | US5942517 Antagonist of alpha(1c) receptors; treatment of benign prostatic hyperplasia |
| 08/24/1999 | US5942512 Method and composition for treating erectile dysfunction |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | US5942243 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/19/1999 | WO1999041387A2 Prostate-associated serine protease |
| 08/19/1999 | WO1999041375A2 Human receptor proteins |
| 08/19/1999 | WO1999041374A2 Human short-chain tnf-receptor family protein |
| 08/19/1999 | WO1999041252A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | WO1999041251A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
| 08/19/1999 | WO1999040917A1 Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction |
| 08/19/1999 | WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1 |
| 08/19/1999 | WO1999030708A3 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof |
| 08/19/1999 | CA2321105A1 Human short-chain tnf-receptor family protein |
| 08/19/1999 | CA2320427A1 Human receptor proteins |
| 08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
| 08/19/1999 | CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors |
| 08/19/1999 | CA2318957A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | CA2317451A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | CA2312991A1 Prostate-associated serine protease |
| 08/18/1999 | EP0935601A2 Arylamino fused pyridines and pyrimidines |
| 08/18/1999 | CN1226168A Monophasic contraceptive method and kit comprising combination of progesterone and estrogen |
| 08/18/1999 | CN1226167A Biphasic comtraceptive method and kit comprising combination of progestin and estrogen |
| 08/17/1999 | US5939560 Inhibitors of DP-mediated processes, compositions and therapeutic methods thereof |
| 08/17/1999 | US5939462 NPY5 receptor antagonists and methods for using same |
| 08/17/1999 | US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists |
| 08/17/1999 | US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies |
| 08/17/1999 | US5939405 Potassium channel modulators |
| 08/17/1999 | US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds |
| 08/17/1999 | CA2151401C Self-loading grenade launcher |
| 08/12/1999 | WO1999040089A1 Benzothiadiazoles and derivatives |
| 08/12/1999 | WO1999040088A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/12/1999 | WO1999040080A1 Hydroxamic and carboxylic acid derivatives |
| 08/12/1999 | WO1999039702A2 Method for regulating size and growth of vascularized normal tissue |
| 08/12/1999 | WO1998058633A3 Microdose therapy of vascular conditions by no donors |
| 08/12/1999 | CA2321025A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors |
| 08/12/1999 | CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 08/12/1999 | CA2317476A1 Hydroxamic and carboxylic acid derivatives |
| 08/11/1999 | EP0934937A1 Azole derivatives as superoxide radical inhibitor |
| 08/11/1999 | EP0934744A1 Nitroglycerin preparation for treatment of erectile dysfunction |
| 08/11/1999 | EP0934321A1 Thienopyrimidine with phosphodiesterase v inhibiting effect |
| 08/11/1999 | EP0934301A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
| 08/11/1999 | EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 08/11/1999 | EP0741744B1 Immunogens against gonadotropin releasing hormone |
| 08/11/1999 | CN1225637A Pyrrole triazines and pyrimidines |
| 08/11/1999 | CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds |
| 08/11/1999 | CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor |
| 08/11/1999 | CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 08/11/1999 | CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/10/1999 | US5935973 Affinity for 5-ht1a, alpha1, alpha2 and/or d2 receptors; antidepressants, anxiolytic agents, psychoses, dyskinesias, parkinson's disease, hypotensive agents, tourette's syndrome, obsessive-compulsive behaviour, panic attacks, social phobias |
| 08/10/1999 | US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds |
| 08/10/1999 | US5935578 Contraceptive vaccine |
| 08/05/1999 | WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038868A1 Azolo triazines and pyrimidines |
| 08/05/1999 | WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038510A1 Derivatives of 1,3,4-oxadiazolone |
| 08/05/1999 | WO1999038506A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction |
| 08/05/1999 | WO1999038504A1 Pharmaceutical uses of optically pure (-)-bupropion |
| 08/05/1999 | WO1999038502A1 Pharmaceutical uses of optically pure (+)-bupropion |
| 08/05/1999 | WO1999038467A1 Treatment of female sexual dysfunction |
| 08/05/1999 | WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
| 08/05/1999 | CA2322289A1 Treatment of female sexual dysfunction |
| 08/05/1999 | CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2319202A1 Preparation for treatment of erectile dysfunction |
| 08/05/1999 | CA2318960A1 Pharmaceutical uses of optically pure (+)-bupropion |
| 08/05/1999 | CA2318920A1 Pharmaceutical uses of optically pure (-)-bupropion |
| 08/05/1999 | CA2318830A1 Derivatives of 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/05/1999 | CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone |
| 08/04/1999 | EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 08/04/1999 | EP0695309B1 Oxytocin antagonist |
| 08/04/1999 | EP0575490B1 GnRH ANALOGS |
| 08/04/1999 | CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 08/04/1999 | CN1224720A Tetracylic derivatives, process of preparation and use |
| 08/03/1999 | US5932737 Peptide compounds for treatment of no-mediated diseases |
| 08/03/1999 | US5932730 Endothelin antagonist |
| 08/03/1999 | US5932607 Imidazole derivatives and process for preparing the same |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932581 Administering sorbitol dehydrogenase inhibitor |
| 08/03/1999 | US5932538 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/03/1999 | CA2170278C Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 07/29/1999 | WO1999037790A1 Human calcineurin b-like protein |
| 07/29/1999 | WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/29/1999 | WO1999037309A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation |
| 07/29/1999 | WO1999037305A1 Pharmaceutically active morpholinol |
| 07/29/1999 | WO1999025360A3 Progestogen-antiprogestogen regimens |
| 07/29/1999 | CA2319199A1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation |
| 07/29/1999 | CA2318268A1 Pharmaceutically active morpholinol |
| 07/29/1999 | CA2317920A1 Human calcineurin b-like protein |
| 07/28/1999 | EP0931080A1 Amorphous paroxetine composition |
| 07/28/1999 | EP0930881A1 Pyrazolinones to treat disturbances of potency |
| 07/28/1999 | CN1223880A Medicine for treating cervical erosion and method for preparing same |
| 07/27/1999 | US5929249 Angiotensin ii receptor antagonists |